Human papillomavirus vaccines: what does the future hold for preventing cervical cancer in resource-poor settings through immunization programs?
Jacob, Martha; Bradley, Janet; Barone, Mark A.
Sex Transm Dis
; 32(10): 635-40, 2005 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16205306
Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Pathways to a cancer-free future: A protocol for modelled evaluations to maximize the future impact of interventions on cervical cancer in Australia.
Fraction of high-grade cervical intraepithelial lesions attributable to genotypes targeted by a nonavalent HPV vaccine in Galicia, Spain.
HPV vaccines - A review of the first decade.
Medroxyprogesterone Acetate Prevention of Cervical Cancer through Progesterone Receptor in a Human Papillomavirus Transgenic Mouse Model.
The impact of human papillomavirus type on colposcopy performance in women offered HPV immunisation in a catch-up vaccine programme: a two-centre observational study.
Pathway to the Papanicolaou smear: The development of cervical cytology in twentieth-century America and implications in the present day.
Effectiveness on high-grade cervical abnormalities and long-term safety of the quadrivalent human papillomavirus vaccine in Japanese women.
Immunogenicity and safety of human papillomavirus (HPV) vaccination in Asian populations from six countries: a meta-analysis.
Safety and efficacy of mucosal immunotherapy using human papillomavirus (HPV) type 16 E7-expressing Lactobacillus-based vaccine for the treatment of high-grade squamous intraepithelial lesion (HSIL): the study protocol of a randomized placebo-controlled clinical trial (MILACLE study).